Tanhaji, Hajina A.
HRN: 14-25-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2024
METRONIDAZOLE 500MG (TAB)
04/01/2024
04/07/2024
PO
750mg
TID
Amoebiasis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes